Cargando…
Coronary microvascular function and visceral adiposity in patients with normal body weight and type 2 diabetes
OBJECTIVE: This study sought to assess whether diabetes affects coronary microvascular function in individuals with normal body weight. METHODS: Seventy‐five participants (30 patients with type 2 diabetes [T2D] who were overweight [O‐T2D], 15 patients with T2D who were lean [LnT2D], 15 healthy volun...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314597/ https://www.ncbi.nlm.nih.gov/pubmed/35357083 http://dx.doi.org/10.1002/oby.23413 |
_version_ | 1784754354685739008 |
---|---|
author | Chowdhary, Amrit Thirunavukarasu, Sharmaine Jex, Nicholas Coles, Lauren Bowers, Charles Sengupta, Anshuman Swoboda, Peter Witte, Klaus Cubbon, Richard Xue, Hui Kellman, Peter Greenwood, John Plein, Sven Levelt, Eylem |
author_facet | Chowdhary, Amrit Thirunavukarasu, Sharmaine Jex, Nicholas Coles, Lauren Bowers, Charles Sengupta, Anshuman Swoboda, Peter Witte, Klaus Cubbon, Richard Xue, Hui Kellman, Peter Greenwood, John Plein, Sven Levelt, Eylem |
author_sort | Chowdhary, Amrit |
collection | PubMed |
description | OBJECTIVE: This study sought to assess whether diabetes affects coronary microvascular function in individuals with normal body weight. METHODS: Seventy‐five participants (30 patients with type 2 diabetes [T2D] who were overweight [O‐T2D], 15 patients with T2D who were lean [LnT2D], 15 healthy volunteers who were lean [LnHV], and 15 healthy volunteers who were overweight [O‐HV]) without established cardiovascular disease were recruited. Participants underwent magnetic resonance imaging for assessment of subcutaneous, epicardial, and visceral adipose tissue areas, adenosine stress myocardial blood flow (MBF), and cardiac structure and function. RESULTS: Stress MBF was reduced only in the O‐T2D group (mean [SD], LnHV = 2.07 [0.47] mL/g/min, O‐HV = 2.08 [0.42] mL/g/min, LnT2D = 2.16 [0.36] mL/g/min, O‐T2D = 1.60 [0.28] mL/g/min; p ≤ 0.0001). Accumulation of visceral fat was evident in the LnT2D group at similar levels to the O‐HV group (LnHV = 127 [53] cm(2), O‐HV = 181 [60] cm(2), LnT2D = 182 [99] cm(2), O‐T2D = 288 [72] cm(2); p < 0.0001). Only the O‐T2D group showed reductions in left ventricular ejection fraction (LnHV = 63% [4%], O‐HV = 63% [4%], LnT2D = 60% [5%], O‐T2D = 58% [6%]; p = 0.0008) and global longitudinal strain (LnHV = −15.1% [3.1%], O‐HV= −15.2% [3.7%], LnT2D = −13.4% [2.7%], O‐T2D = −11.1% [2.8%]; p = 0.002) compared with both control groups. CONCLUSIONS: Patients with T2D and normal body weight do not show alterations in global stress MBF, but they do show significant increases in visceral adiposity. Patients with T2D who were overweight and had no prior cardiovascular disease showed an increase in visceral adiposity and significant reductions in stress MBF. [Image: see text] |
format | Online Article Text |
id | pubmed-9314597 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93145972022-07-30 Coronary microvascular function and visceral adiposity in patients with normal body weight and type 2 diabetes Chowdhary, Amrit Thirunavukarasu, Sharmaine Jex, Nicholas Coles, Lauren Bowers, Charles Sengupta, Anshuman Swoboda, Peter Witte, Klaus Cubbon, Richard Xue, Hui Kellman, Peter Greenwood, John Plein, Sven Levelt, Eylem Obesity (Silver Spring) ORIGINAL ARTICLES OBJECTIVE: This study sought to assess whether diabetes affects coronary microvascular function in individuals with normal body weight. METHODS: Seventy‐five participants (30 patients with type 2 diabetes [T2D] who were overweight [O‐T2D], 15 patients with T2D who were lean [LnT2D], 15 healthy volunteers who were lean [LnHV], and 15 healthy volunteers who were overweight [O‐HV]) without established cardiovascular disease were recruited. Participants underwent magnetic resonance imaging for assessment of subcutaneous, epicardial, and visceral adipose tissue areas, adenosine stress myocardial blood flow (MBF), and cardiac structure and function. RESULTS: Stress MBF was reduced only in the O‐T2D group (mean [SD], LnHV = 2.07 [0.47] mL/g/min, O‐HV = 2.08 [0.42] mL/g/min, LnT2D = 2.16 [0.36] mL/g/min, O‐T2D = 1.60 [0.28] mL/g/min; p ≤ 0.0001). Accumulation of visceral fat was evident in the LnT2D group at similar levels to the O‐HV group (LnHV = 127 [53] cm(2), O‐HV = 181 [60] cm(2), LnT2D = 182 [99] cm(2), O‐T2D = 288 [72] cm(2); p < 0.0001). Only the O‐T2D group showed reductions in left ventricular ejection fraction (LnHV = 63% [4%], O‐HV = 63% [4%], LnT2D = 60% [5%], O‐T2D = 58% [6%]; p = 0.0008) and global longitudinal strain (LnHV = −15.1% [3.1%], O‐HV= −15.2% [3.7%], LnT2D = −13.4% [2.7%], O‐T2D = −11.1% [2.8%]; p = 0.002) compared with both control groups. CONCLUSIONS: Patients with T2D and normal body weight do not show alterations in global stress MBF, but they do show significant increases in visceral adiposity. Patients with T2D who were overweight and had no prior cardiovascular disease showed an increase in visceral adiposity and significant reductions in stress MBF. [Image: see text] John Wiley and Sons Inc. 2022-03-31 2022-05 /pmc/articles/PMC9314597/ /pubmed/35357083 http://dx.doi.org/10.1002/oby.23413 Text en © 2022 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society (TOS). https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | ORIGINAL ARTICLES Chowdhary, Amrit Thirunavukarasu, Sharmaine Jex, Nicholas Coles, Lauren Bowers, Charles Sengupta, Anshuman Swoboda, Peter Witte, Klaus Cubbon, Richard Xue, Hui Kellman, Peter Greenwood, John Plein, Sven Levelt, Eylem Coronary microvascular function and visceral adiposity in patients with normal body weight and type 2 diabetes |
title | Coronary microvascular function and visceral adiposity in patients with normal body weight and type 2 diabetes |
title_full | Coronary microvascular function and visceral adiposity in patients with normal body weight and type 2 diabetes |
title_fullStr | Coronary microvascular function and visceral adiposity in patients with normal body weight and type 2 diabetes |
title_full_unstemmed | Coronary microvascular function and visceral adiposity in patients with normal body weight and type 2 diabetes |
title_short | Coronary microvascular function and visceral adiposity in patients with normal body weight and type 2 diabetes |
title_sort | coronary microvascular function and visceral adiposity in patients with normal body weight and type 2 diabetes |
topic | ORIGINAL ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314597/ https://www.ncbi.nlm.nih.gov/pubmed/35357083 http://dx.doi.org/10.1002/oby.23413 |
work_keys_str_mv | AT chowdharyamrit coronarymicrovascularfunctionandvisceraladiposityinpatientswithnormalbodyweightandtype2diabetes AT thirunavukarasusharmaine coronarymicrovascularfunctionandvisceraladiposityinpatientswithnormalbodyweightandtype2diabetes AT jexnicholas coronarymicrovascularfunctionandvisceraladiposityinpatientswithnormalbodyweightandtype2diabetes AT coleslauren coronarymicrovascularfunctionandvisceraladiposityinpatientswithnormalbodyweightandtype2diabetes AT bowerscharles coronarymicrovascularfunctionandvisceraladiposityinpatientswithnormalbodyweightandtype2diabetes AT senguptaanshuman coronarymicrovascularfunctionandvisceraladiposityinpatientswithnormalbodyweightandtype2diabetes AT swobodapeter coronarymicrovascularfunctionandvisceraladiposityinpatientswithnormalbodyweightandtype2diabetes AT witteklaus coronarymicrovascularfunctionandvisceraladiposityinpatientswithnormalbodyweightandtype2diabetes AT cubbonrichard coronarymicrovascularfunctionandvisceraladiposityinpatientswithnormalbodyweightandtype2diabetes AT xuehui coronarymicrovascularfunctionandvisceraladiposityinpatientswithnormalbodyweightandtype2diabetes AT kellmanpeter coronarymicrovascularfunctionandvisceraladiposityinpatientswithnormalbodyweightandtype2diabetes AT greenwoodjohn coronarymicrovascularfunctionandvisceraladiposityinpatientswithnormalbodyweightandtype2diabetes AT pleinsven coronarymicrovascularfunctionandvisceraladiposityinpatientswithnormalbodyweightandtype2diabetes AT levelteylem coronarymicrovascularfunctionandvisceraladiposityinpatientswithnormalbodyweightandtype2diabetes |